VEGF Signaling in Neurological Disorders

Area of Science:

• Neuroscience
• Vascular Biology
• Pathology

Background:

• Vascular endothelial growth factor (VEGF) is vital for blood vessel formation and brain functions, including neuroprotection.
• Excessive VEGF can disrupt brain barriers, causing edema and inflammation, and is implicated in conditions like hydrocephalus.
• Heparin-binding epidermal growth factor (HB-EGF) activates VEGF signaling, contributing to neurological disorders.

Purpose of the Study:

• To review causes of death from neurological disorders, focusing on cerebrovascular and age-related conditions.
• To explore the mechanism of treating angiogenesis-dependent pathological events using VEGF antagonisms.
• To update understanding of VEGF signaling in neurological diseases and potential therapeutic interventions.

Main Methods:

• Literature review of studies on VEGF signaling in neurological disorders.
• Analysis of the Global Burden of Disease data for mortality causes.
• Examination of molecular targets and pathways involved in VEGF signaling.

Main Results:

• VEGF plays a dual role in the brain, mediating essential functions but also contributing to pathology when excessive.
• HB-EGF activation of VEGF signaling is linked to hydrocephalus and subarachnoid hemorrhage.
• VEGF signaling modulation is critical, with concentration, timing, and route being important factors.

Conclusions:

• Understanding VEGF's complex role is key to developing treatments for neurological disorders.
• Targeting specific VEGF pathways may offer novel therapeutic approaches for stroke and other neurological conditions.
• Modulating VEGF signaling holds promise for reducing mortality associated with cerebrovascular and age-related neurological diseases.